yx!T×ùà ØÁ‰§êE Ä!äK‰s!ÃêE Êp$Bl!

K mNG|T
THE GOVERNMENT OF THE FEDERAL
DEMOCRATIC REPUBLIC OF ETHIOPIA

yxµÆb! _b” Æl|LÈN

ENVIRONMENTAL PROTECTION AUTHORITY

mmRÃ xND
DIRECTIVE ONE
bLW_ ?ÃêN XNQS”s@ãC §Y lms¥‰T y¸qRb# ¥mLkÒãC YzT
THE CONTENTS OF APPLICATIONS FOR UNDERTAKING TRANSACTIONS
INVOLVING MODIFIED ORGANISMS

xÄ!S xbÆ
_R 2000
ADDIS ABABA
January 2008

1
 mm¶Ã q$_R 1

bLW_ HÃêN XNQS”s@ãC §Y lms¥‰T y¸qRb# ¥mLkÒãC YzT ን lmwsN ywÈ

mm¶ÃÝÝ

bLW_ ?ÃêN XNQS”s@ãCN l¥µÿD y¸qRb# yf”D _Ãq& ¥mLkÒãC xÚÚF bx!T×ùÃ

WS_ tmúúYnTN k›lM ›qF x\‰R UR tS¥¸nTN ለማምጣት y¸flgWN ê ê ይዘት መለየት

xSf§g! bmçn#½

yxµÆb! MKR b@T by¥mLkÒW mgl{ y¸gÆW mr© MN mçN XNÄlbT ytS¥¥ Slçn½

በ dHNn ተ ?YwT xêJ q$_R xNq{ 22 m\rT YH mm¶Ã w_aLÝÝ

KFL xND

1. |û

YH mm¶Ã «bLW_ ?à ዋ N XNQS”s@ãC §Y lm ሰ¥‰T y¸q ር b# ¥mLkÒãC Y ዘ TN

lmw ሰ N ywÈ mm¶Ã q$_R 01¼2001´ tBlÖ l!-ቀ S YC§LÝÝ

DIRECTIVE No. ONE

DIRECTIVE ISSUED TO DETERMINE THE CONTENTS OF APPLICATIONS

FOR UNDERTAKING TRANSACTIONS INVOLVING MODIFIED ORGANISMS

1
WHEREAS it is important to determine the major contents of applications for

transactions involving modified organisms to bring about consistency within Ethiopia and

harmonization internationally,

WHEREAS, the Environmental Council has agreed upon the information needed to be

included in every application;

THEREFORE, this directive is issued in accordance with Article 22 of the Biosafety

Proclamation No. …….

1. Designation

This directive may be cited as “Directive No. 01/ 2009 issued to determine the contents

of applications for undertaking transactions involving modified organisms.”

2
2. TRÙ»

bz!H xêJ WS_½

1. «lgbà ¥QrB´ ¥lT LW_ ?ÃWN lt-@n LqT l¥êL kGN²b@ ymn=

SMMnTN ktqbl# b“§ bXRĬ MGBnT mS-TN =Mé lîSt¾ wgN b>Ã+½ bSõ¬ wYM

bl@§ mNgD ¥St§lF nWÝÝ

2. «LW_ ?ÃW´ ¥lT sW \‰> yçn½ wYM kl@§ ?ÃW ytwsd Yh#N

kQ¶T ytwsd wYM XNdxÄ!S ytqmm ÆYtêR zrmL wYM l@§ N_r ngR SltkttbT

yzrmlÖC Yzt$ wYM yÆ?R† KStT ytlw-bT ?ÃW nWÝÝ

3. «መሥራት´ ¥lT bzmÂêE ጥበበ ?YwT LW_ ?ÃW እንዲገኝ ማድ r ግ

nWÝÝ

#
4. c¨<$ TKƒ ¾}ðØa c¨< ¨ÃU uQÓ ¾c¨<’ƒ Swƒ ¾}cÖ¨< ›"M ’¨<&

5. «Æl|LÈN´ ¥lT bxêJ q$_R 295¼1995 ytÌÌmW yx!T×ùà ØÁ‰§êE

Ä!äK‰s!ÃêE ¶p$Bl!K yxµÆb! _b” Æl|LÈN nWÝÝ

6. «ተቆጣጣሪ´ ማለት የደህንነተ ህይወት አዋጅ፣ በስሩ የወጣ ማንኛውም

ደንብና ወይም መመሪያ መከበሩን ለማረጋገጥ የፍተሻና ሌላ የቁጥጥር እርምጃ እንዲወስድ

ባለሥልጣኑ በሚያወጣው መመሪያ መሠረት የተሾመ ሰው ነው፡፡

7. «xmLµC´ ¥lT y¸-YqWN :NQS”s@ l¥µÿD ከግንዛቤ የመነጨ SMMnT

XNÄ!s-W lÆl|LÈn# Ãmlkt sW nWÝÝ

8. «XNQS”s@´ ¥lT LW_ ?ÃWN m|‰TN¿ wYM lTMHRT½

lMRMR½ lMRT½ wd xgR WS_ l¥SgÆT½ wd WÀ lm§K½ bT‰Nz!T l¥St§lF½ lt-@n
LqT½ bZG አጠቃቀም l¥MrT½ l¥ÙÙZ½ lgbà l¥QrB½ lsW wYM lXNSú bmD`n!TnT
lm-qM½ lMGBnT½ lmñnT wYM lÍB¶µ _Ê :”nT ¥êL¿ ነው፡፡

3
2. Definitions

For the purpose of this Proclamation:

1. ‘Placing on the market’ means obtaining an advance informed agreement for deliberate

release or making available to third parties a modified organism for any use by selling,

giving away or in any other way, and includes giving as aid food.

2. ‘Modified organism’ means any biological entity which has been artificially synthesized, or

in which the genetic material or the expression of any of its traits has been changed by the

introduction of any foreign gene or any other chemical whether taken from another

organism, from a fossil organism or artificially synthesized.

3. ‘Making’ means the development of a modified organism through modern biotechnology;

4. 'Person' includes any natural or juridical person.

5. 'Authority' means the Environmental Protection Authority of the Federal Democratic

Republic of Ethiopia established pursuant to Proclamation No. 295/2002.

6. ‘Inspector’ means a person appointed pursuant to the directives issued by the Authority to

undertake examination and any other control measures to ensure compliance with the

proclamation on biosafety regulations or directives issued under it.

7. ‘Applicant’ means any person who submits an application to the Authority seeking an

advance informed agreement to be engaged in a transaction.

8. 'Transaction' means any making or use of any modified organism in teaching, research,

production, import, export, transit, deliberate release, production under contained use,

transport, placing on the market, or use as a pharmaceutical, as food, as feed or for

processing.

4
9. «ዝግ አጠቃቀም´ ¥lT በሰ W wYM በእንሰሳት ጤና wYM በአካባቢ ላይ

y¸ktL ÃL¬qd t}:ñN lmk§kL ከልውጥ ሕያዋን ጋራ የተያያዘ ጠንቅን የመቋቋምያ ስልት

አተገባበርን ለመወሰን በወጣው መመሪያ ቁጥር 03/2001 እንደ ሁኔታው በዓንቀፅ 4.8 ወይም 4.9

እንደተዘረዘረው በቁሳዊና በንጥረ ነገራዊ ከለላ ታጥረ W LW_ ?ÃêN እንዲ s„½ XNÄ!ÃDg#½

XNÄ!k¥c$½ XNÄ!wgÇ wYM ትም H ርት N ና MRMR ን ጨምሮ በሆነ l@§ መንገድ በ_QM

§Y XNÄ!Wl# ማድረግ nWÝÝ

10. «የተጤነ LqT´ ¥lT kGN²b@ bmn= SMMnT msrT LW_ ?ÃWN

ለንግድ፣ ለምግብ፣ ለእርዳታ MGB½ xµÆb!N l¥}ÄT½ l¥St¥¶ÃnT½ lMRMR½ lmStêT

b@T½ lW¦ WS_ XRƬ½ lXNSúT mñ½ lsW wYM lXNSúT HKM wYM ll@§ _QM

b¥êL ወደ xµÆb! እንዲ Är ስ ማድረግ nWÝÝ

11. «-NQ´ ¥lT kyt$¾WM XNQS”s@ bq_¬ wYM btzêê¶ mNgD½

bx+R½ bmµkl¾ wYM brJM g!z@ bsW wYM bXNSú -@½ bBZ/ ?YwT½ bxµÆb!½

b¥HbrsïC ¥Hb‰êE½ x!÷ñ¸ÃêE½ wYM ÆH§êE h#n@¬ ወይም በአገሪቷ ኢኮኖሚ፣ §Y l!

ktL y¸CL xdU nWÝÝ

12. «ßéè÷L´ ¥lT በአዋጅ ቁጥር 362/1995 የፀደቀ W የብዝ/ ሕይወት ኮንቬንሽ n# yµR¬ኼ Â

የደሕንነተ ሕይወት ፕሮቶኮል ነ W፡፡

5
9. "Contained use” means any operation in which modified organisms are made, grown,

stored, destroyed or used in any other way including for teaching and research isolated by

physical and chemical barriers as specified in Articles 4.8 or 4.9 of Directive no. 03/2009

issued to determine the procedures of a risk management strategy for dealing with

accidents involving modified organisms, as the case may be, with a view to effectively

preventing their contact with, and their unintended impact on, humans, animals or the

external environment.

10. ‘Deliberate release’ means any introduction into the environment of a modified organism

based on an advance informed agreement and includes, inter alia, any use in commerce,

food, aid food, remediation, teaching, research, greenhouses, aqua-culture, animal feed or

other inputs for animals, medicines for humans or animals, or disposal.

11. ‘Risk’ means direct or indirect, short, medium or long-term danger that may befall human or

animal health, biological diversity, the environment, socio-economic or cultural conditions

of local communities or the economic condition of the country from any transaction.

12. ‘Protocol’ means the Cartagena Protocol on Biosafety to the Convention on Biological

Diversity ratified through Proclamation No 362/2003.

6
3. mmRÃW tfɸ Sl¸çNÆcW XNQS”s@ãC

YH mm¶Ã በማንኛውም እንቅስቃሴ ላይ tfÚ¸nT YñrêLÝÝ

y¸ktl#T DNUg@ãC bn-§ ytÚû s!çn#M XNdyh#n@¬cW ብዙውንም Ymlk¬l#ÝÝ

4. x-”§Y mr©ãC

h. yxmLµC SM xD‰š½

l. \‰t®CNÂ የሰለጠኑባቸ W mS÷CN y¸g ልጹ mr©ãCÝ

ßéjK ቱ N l¥qD lmtGbR½ XNÄ!h#M lq$__R½ lKTTL ld~NnT `§ðnT

ÃlÆcW sãC SM½ |L- l@lÖC yB”T mmSkRÃãC¿ btlYM y`§ðW úYNtEST

SM yClÖ¬ B”T mmSk¶Ã½

/. XNQS”s@W y¬sbW lt-@n LqT Yh#N½ wYM bmmRÃ q$_R 3 bxNq{ 4.8

ወይም በዓንቀፅ 4.9 bts-W TRg#M lZG h#n@¬½ y¸ÃúY mGlÅ፡፡

7
3. Transactions subject to this Directive

This Directive shall apply to any transaction.

Any of the following provisions that is written in the singular shall also apply to the

plural as the case may be.

4. General information

a) Name and address of applicant

b) Information on personnel and training; name, training and other qualifications of

persons responsible for planning and carrying out the implementation of the project,

including those responsible for supervision, monitoring and safety, in particular the name

and qualifications of the responsible scientist.

c) A statement specifying whether the transaction is an intended release or contained use

as defined in Articles 4.8 or 4.9 of Directive No.3.

8
 5. LW_ HÃýN y¸mlkT mr©

5.1 yw§íC ?ÃêN ÆHRÃT¿

h. yt²wrW ÆYtêR zrmL MN+ yçnW ሕያ W ሳይንሳዊ ስም ½ ሲኖርም ytlMì ስም ½

l. yt²wrW ÆYtêR zrmL tqÆY ?Ã ዉ úYNúêE SM½ s!ñRM ytlMì SM½

/. bKStT _NQ„ WS_ ytµtt$ ባይተዋር zrmlÖC MNôC ከ çn#T ?ÃêN ሁሉ U‰ y¸²mÇ

ል W ጥ ሕያ ý በጥቅም በሚ W ልበት አካባቢ የሚገኙ ZRÃãC úYNúêE SäCÂ s!ñ„M

የተለምዶ SäC½ wYM yÆHRYN KStT y¸nµW N_r ngR ?ÃýN ÆlbT kçn ylw-W

k?Ãý ጋራ የሚዛመዱ ZRÃãC ሳይንሳዊ ስሞች ½ ሲኖሩም ytlMì ስሞች ½

5.2 yn#KlYK xs!D wYM yÆHRY KStTN y¸nk# l@lÖC N_r ngéC ÆHRÃT

h. n#KlYK xs!Ç wYM yÆ?RY KStTN ynµW l@§ N_r ng„ btf_é ytgß wYM ytqmm

Slmçn#½

l. N_r ng‰êE QR[#½

/. y¸kStW Æ?RY MNnT½

m. N_r ng„N Ãmn=W ?ÃW½ wYM ÆlbT kçn ytlw-W yLW_ ?Ãý፣ úYNúêE SMÂ

ytlMì SäC½

\. xµ§êE zrm§êE MLKèC½

5. Information on to the modified organism

5.1 Characteristics of the parental organisms

9
 a) scientific name, and when available also common name, of the donor of the

transgene.

b) scientific name, and when available also common name, of the recipient organism

of the transgene.

c) scientific names, and when available also common names, of all species that are

related to any of the organisms from which any of the transgenes in the expression

cassette have been taken, or if the chemical that affects trait expression has been

inserted in situ, scientific names, and when available also common names, of

species that are related to the modified organism and that occur or are likely to

occur in the area where it is to be used.

5.2 Characteristics of nucleic acids or other molecules that affect trait expression

a) Whether the nucleic acid or other chemical that has affected trait expression is

natural or synthetic.

b) Chemical structure.

c) Description of the trait that it expresses.

d) Scientific name and, when available other names, of organisms from which the

molecule has been taken, or if modified in situ, scientific name, and when

available, other names of the modified organism.

e) Phenotypic and genetic markers.

r. bt²wrW ÆYtêR zrmL sÀ tqÆY ZRÃãC (bw§íC) mµkL ÃlW ZMD½ wYM

ytqmm kçnM tmúúY yÆ?RY KStT nK N_r ngR çcW ZRÃãC½

10
 s. የ MNnT ymñR wYM yxlmñR ¥wQà zÁãC mGlŽ

¹. yzÁã ቹ B”T xSt¥¥"nT x¦²êE mGlŽ yzÁã ቹ$ yl‘nT ClÖ¬½

q. w§íc$ btf_éxcW½ wYM ytqmm kçnM tmúúY yÆ?RY KStT nK N_r ngR çcW

ZRÃãC½ y¸gß#ÆcW xµÆb!ãC½ b‘ãÒcW½ tb‘ãÒcW½ _g¾ãÒcW½

twÄĶãÒcW½ tdUUðãÒcW t¹µ¸ãÒcW ZRÃãC mLK› MD‰êE SR+èÒcW

mGlŽ

b. kl@lÖC ?ÃêN U‰ l!ñR y¸ClW yn#KlYK xs!ìC wYM yl@lÖC yÆHRY KStT
nK N_r ngéC mt§lF wYM mlêw_½
t. y§ï‰è¶ Ñk‰ãC LW_ ?à ዉ y¸ñRbTN wYM b_QM §Y y¸WLbTN SnmHD ራዊ
h#n@ታ bTKKL y¸ÃNiÆRq$ ስ lmçÂcW b¸ÃúMN mNgD n#KlYK xs!ìC ና
l@lÖC yÆ?RY KStT nK N_r ngéC úYlw-# ymöyT xSt¥¥"nTÂ YHN xSt¥¥"nT
y¸nk# t}:ñãC ZRZR½
c. bn#KlYK xs!ÇÂ bÆ?RY KStT nK ¥N¾WM l@§ N_r ng„ tGÆR §Y t}:ñ l!Ãm-#
y¸Cl# N_r ng‰êE½ Sn HYw¬êE½ yxyR NBrT እንደዚሁም l@lÖC h#n@¬ãC፣
እና yt}:ñãc$ m-ñC½
5.3 yxD‰> ÆHRÃT

h. yxD‰¹# tf_é MN+½

l. LW_ ሕ Ã ዉ N lm|‰T wd tqÆY ZRÃ btkttW yKStT _NQR WS_ ynbr T

‰NS±øN½ l@§ xD‰> X ÆHRY y¥YkSt$ yzrmlÖC q$‰ôC N_r ng‰êE
QNJT QdM tktL½
f) Degree of relatedness between transgene donor and recipient (between parental)

organisms; or if synthetic, species that naturally have the most similar trait affecting

molecule.

g) Description of identification and detection techniques.

h) Sensitivity, reliability (in quantitative terms) and specificity of the techniques.

11
 i) Description of the geographic distribution and of the natural habitats of the

parental organisms, or if synthetic, of the species with the most similar trait

affecting chemical; their predators, preys, parasites, competitors, symbionts and

hosts.

j) Potential for nucleic acids or other chemicals involved in trait expression being

transferred to, or exchanged with, other organisms.

k) Verification of the stability of the nucleic acids and other chemicals involved in

trait expression and factors affecting their stability, taking into account the

relevance of laboratory experiments to the ecological conditions under which the

modified organism is to live or to be used.

l) Factors (inter alia chemical, biological, climatic) influencing the functional levels of

the nucleic acid and any other chemical that affects trait expression, and how the

functional level changes.

5.3 Characteristics of the vector

a) Nature and source of the vector

b) Sequence of transposon, other vector and other non-coding genetic segments used to
construct the expression cassette and to introduce it into the recepient organism to
produce the modified organism.
/. bLW_ ?à ዉ WS_ yxD‰¹# ï¬ ymlêw_ m-N X ktqƆ ZRà wd l@lÖC Z‰ÃãC

zrmlÖCN wYM l@lÖC yÆ?RY KStT nK N_r ngéCN y¥St§lF xQѽ XNÄ!

h#M Xnz!HN ÆHRÃT lmlµT y¸ÃSCl# zÁãC½

5.4 yLW_ ሕያዉ ÆHRÃT

h. የሕያዉን የአለዋወጥ ሂደት የሚመለከቱ መረጃዎች

1. ሕያዉ XNÄ!lw_ ytdrgÆcW zÁãC½

12
 2. wd tqÆY ?Ã ዉ wYM wd ¥N¾WM n#KlYK xs!D wYM yßétEN sNslT wYM

l@§ yÆHRY KStT nK N_r ngR ygÆWN N_r ngR lmKtT½ wYM ¥N¾WN

n#KlY ክ xs!D wYM l@§ yÆ?RY KStT nK N_r ngR ን lmlw_ b_QM §Y yê ሉ

zÁãC½

3. XyxNDxNÇN yKStT _NQR knxD‰¹# U‰ y¸ÃúY mGlŽ

4. ytkttW yKStT _NQR µL¬wq$ ?Yw¬êE N_r ngéC nÉ mçN½

5. yÑl# xD‰ëC q$_R yxD‰ëC q$R_‰ôC q$_R¿ ytlw-#½ ygb#½ ytwgÇ

n#KlYK xs!ìC wYM yßétEN sNslT q$R_‰ôC½ btlYM xdg¾ mçÂcW

y¬wq½

6. wd LW_ ሕያዉ WS_ kgb#T n#KlYK xs!ìC x-gB b100 kbp wd §YÂ wd¬C

Ãl#T ytqÆY ?Ãý n#KlYK xs!ìC X y»tEl@>N h#n@¬½

c) Frequency of mobilization of the vector when inserted into the rcepient organism and

transfer capabilities of genes or other trait affecting chemicals from the recipient

organism to other organisms and methods of determination of the mobilization and

the transfer.

5.4 Characteristics of the modified organism

(a) Information relating to the modification:

1) Methods used for the modification

13
2) Methods used to construct and introduce the inserts into the recipient organism or

into any nucleic acid or protien sequence or other chemical; or used to change the

chemical composition of any nucleic acid or other chemical that affects trait

expression.

3) Description of each expression cassette, including the vector.

4) Purity of the inserted expression cassette from any unknown biochemicals.

5) Number of intact vectors and truncated vectors. Sequence, functional identity and

location of the altered or inserted or deleted nucleic acid or protien segments with

particular reference to any known harmful sequence.

6) Sequence and methylation pattern of the recipient nucleic acid as far as 100 kbp

up and down stream from all nucleic acid inserts

l. ስለ LW ጥ ሕያዉ mr©

1. ሳይንሳዊና የተለምዶ ስሞችና የተለወጠበት ክንዋኔ ½

2. yLW_ ሕያዉ xµ§êE h#n@¬ mGlŽ btlYM ytkst$ XNÄYkst$ y¬gÇ

ÆH¶ÃT½

3. bLW_ ሕያዉ WS_ yqrW xD‰> XÂ ከሰጪ W ygÆlT n#KlYK xs!D wYM

yÆ?RY KStT nK l@§ N_r ngR QR}Â m-N½

4. yÆHRà ቱ XRU¬½

14
 5. ygÆlT ÆYtêR zrmL wYM yÆ?RY KStT nK l@§ N_r ngR yKStT m-N½

YHN lmlµT y¸ÃSCl# zÁãC lk!n¬cW½

6. ytkstW ßétEN tGÆR½

7. kgb#T wYM N_r ng‰êE Yz¬cW ktlw-W xs!ìC b100kbp wd §Y wd¬C

ytqm-#T ytqÆ ዩ zrmlÖC bÆHRYnT ymk\T h#n@¬Â m-N½

8. LW_ ?Ã ዉ N lmlyTÂ l¥wQ b_QM §Y y¸Wl# zÁãC lk!nT½ xSt¥¥"nT (bx¦Z

y¸gl{) XÂ l‘nT½

9. LW_  ሕያዉ t-!ñ kxh#N bðT Sl mlqq$ wYM b_QM §Y Slmêl# y¸gL} mr©½

10. bsW wYM bXNSúT -@½ bBZ¦ ?YwT½ bxµÆb!½ b¥~brsïC ¥~b‰êE

wYM x!÷ñ¸ÃêE h#n@¬ãC½ SnMGƉêE Xs@èC wYM ÆH§êE

h#n@¬ãC wYM bxgR x!÷ñ¸ §Y l!dRs# y¸Cl# -NöC½

11. btf_éxêE |R›t mHDéC WS_ ym‰b!à g!z@½ „µÆêE X x!„µÆêE ym

‰ÆT x#d ቶች ½

(b) Information on the modified organism

1) Scientific and common names and transformation event.

2) Description of phenotypic characteristics and in particular any new traits and

characteristics which may be expressed or no longer expressed.

3) Structure and amount of any vector and donor nucleic acid or other trait affecting

chemical remaining in the modified organism.

4) Stability of the traits.

15
5) Expression of the introduced new genetic material or other chemical that affects

trait expression and methods and sensitivity of measurement.

6) Function of the expressed protein.

7) Expression levels of the recipient's genes situated as far as 100 kbp up and down

stream from all nucleic acid inserts or chemical changes.

8) Sensitivity, reliability (in quantitative terms) and specificity of detection and

identification techniques of the modified organism.

9) History of previous releases or uses of the modified organism.

10) Risks to human or animal health, biological diversity, the environment, socio-

econmic conditions, ethical values or cultural norms of local communities or the

economic condition of the country.

11) Generation time in natural ecosystems, sexual and asexual reproductive cycles.

12. zRN½ Çk@N½ XSKlÖé¹!ÃN wYM l@lÖC xµ§TN bmF-R y¥YS¥¥W g!

z@N y¥úlF ClÖ¬WÂ kwQèC U‰ ymlêw-# h#n@¬ mr©ãC½

13. b>¬ y¥SÃZ½ ymLkF½ ymmrZ½ y¥_”T½ xlR©! ymqSqS½ b>¬ x²¥C ymçN

Cl֬ b>¬ XNÄ!ÃmÈ wd sW wYM wd XNSúT y¸Ã²Mt$T ?ÃêN ¥NnT½

b>¬ y¸NçNÆcW ?ÃêN½ y¥Y¯Ç ŠYrîCN wd b>¬ xMÀnT ymlw_ xQM፣

l@lÖC ?ÃêNN ymWrR xQM½ የ n#KlYK xs!ዶች wYM የ l@lÖC yÆ?ርይ

KStT nK N_r ngé ች wd l@lÖC Z ር ÃãC HêúT wYM HBr HêúT የመግባት

xQM½

16
 14. xNtEÆ×tE÷CN ymÌÌM ›QM ynz!H xNtEÆ×tE÷C sW wYM yb@T

XNSúT በ b>¬ XNÄYÃz# mk§kà wYM k?mM mD`n!T çñ y¥gLgL -”¸nT½

15. LW_ ?à ዉ bxµÆb!ÃêE £dèC y¸ÅwtW ¸Â½ ¥lTM `YLN wd MGB MRTnT

በ mlw_ ClÖ¬½ l:ፀ êT b¸ÃSfLg# N_r ngéC x#dT½ bq$úêE xµL mbSbS½

bTN ፈ ú X bl@lÖC tGƉT½

16. LW_nTN wd l@lÖC ?ÃêN y¥UÆT -NQ½

ሐ. bZRÃW ytdrg# l@lÖC lWõC ZRZR½

5.5 b-@Â §Y l!dRs# y¸Cl# t}:ñãCN ytmlkt

h. LW_ ሕያዉ bsW wYM bXNSúT §Y y¸ÃdRsW mR²¥nT½ yxlR©! qS”>nT½

y>L xµL xg#ÄYnT wYM çRäNN múYnT½

12) Information on survival, including seasonality and the ability to form seeds,

spores, sclorotia and other survival structures.

13) Pathogenicity, infectivity, toxicity, virulence, allergenicity, ability to be a carrier

(vector) of pathogens, identity of possible vectors to transimit it to humans or

animals as a disease causing agent, host range, possible activation of latent

viruses, ability to colonize other organisms, ability of nucleic acids or other

molecules that affect trait expression to be introduced into the cells or tissues of

other species.

14) Antibiotic resistance, and potential use of these antibiotics in humans or domestic

animals for prophylaxis or therapy.

17
 15) Involvement in environmental processes: primary production, nutrient cycling,

decomposition of organic matter, respiration and other activities.

16) Risk of passing modification to other organisms.

(c) History of previous genetic modifications

5.5 Considerations of impacts on health

a) Toxic, allergenic, tetratogenic or hormone mimicking effects of the modified

organism on humans or animals.

l. የ LW_ ሕያዉ t}:ñ bsW wYM bXNSúT §Y bmR²¥nT½ bx ለ R©! qS”>nT½ b>L

xµL xg#ÄYnT½ wYM bçRäN múYnT xµ*Ã ksÀÂ ktqÆY wYM LW_ µLçn#T

w§J ?Ãên# UR s!nÉiR½

/. wd xÄÄ!S ï¬ãC ym²mT xQM½

m. LW_ ?Ãý b>¬N ymk§kL xQÑ btà§lT sW wYM XNSú §Y b>¬ y¥SÃZ½ xlR©!

ymqSqS½ y>LN xµL y¥g#dL wYM çRäNN ymMsL t{:ñ y¸ÃSkTL kçn y¸ktl#T

mr©ãC ÃSfLU ሉ ½

1. l!ÃdRS y¸C§cW b>¬ãC wYM yxµL g#ÄèC b>¬ y¸ÃSYZÆcW

mNgìC½ ym²mTÂ y¥_”T m-NN =Mé½

2. t§§ðnT½

3. b>¬ l!ÃSYZ y¸ClW m-N½

18
 4. b¸ÃmÈW b>¬ t-qEãc$ ተጠቂዎችን የመቀያየር ችሎታው፣

5. ksãC wYM kl@lÖC ?ÃêN WÀ ymöyT xQM½

6. x²¥C ?ÃêN wYM l@lÖC ym²mÒ mNgìC½

7. SnHYw¬êE XRU¬½

8. ytgb! HKMÂ mñR½

6. yLW_ Hà ዉ yt-@n LqT h#n@¬N y¸lqQbT xµÆb!N y¸mlk ቱ

mr©ãC

6.1 SlLq ቱ$ mr©ዎች

b) Comparison of the modified organism with the donor and recipient or unmodified

parental organisms regarding pathogenicity, allergencity, teratogencity or mimicking

hormones in humans or animals.

c) Capacity for colonization.

d) If the organism is pathogenic, allergenic, teratogenic or hormone mimicking to a

humans or an animal which is immunocompetent, the following information is

required:

1) diseases or disability that may be caused and mechanism of pathogenicity

including invasiveness and virulence

2) communicability

3) infective dose

4) host range and possibility of alteration of hosts

19
 5) possibility of survival outside of humans or other organisms

6) vectors or means of dissemination

7) biological stability

8) availability of appropriate therapies

6. Information relating to the conditions of deliberate release and the receiving

environment

6.1 Information on the release

h. t-!ñ ሊ drG y¬qdW LqT h#n@¬½ xSf§g!nT Yg¾L tBlÖ y¬sbW W-@T½

l. Lqt$ y¸fiMÆcW qÂTÂ y¸öYbT g!z@½

/. yï¬W SÍT½

m. Lqt$ y¸drGbT zÁ½

\. y¸lqqW LW_ ሕያ W መጠን ½

r. LqT የ¸µÿDbT ï¬ ZGJT (yxSt‰rS xYnT zÁ½ y¥:DN q$Íé½ ymSñ L¥T

wYM l@lÖC DRg!èC) ½

s. bLqt$ £dT y\‰t®CN dHNnT lm-bQ y¸wsÇ XRM©ãC½

¹. Lqt$ µb” b“§ bï¬W §Y y¸drg# ¥StµkÃãC½

q. lÑk‰ wYM b_QM §Y l¥êL የ LW_ ሕያዉ ል qT s!Ãb” XNÄ!wgD wYM

XNÄ!mKN l¥DrG b_QM §Y y¸Wl# zÁãC½

b. qdM s!L ktdrg የ LW_ ሕያዉ LqT ytgß# W-@èC¿ btlYM btlÆ m-ñC btlÆ

|R›t m?DéC½

20
6.2 yxµÆb!W mr©

t ጢ ñ y¸drG LqT y¸fiMbTN ï¬Â bx-”§†M xµÆb!WN y¸gL{ ytৠmr© mQrB

xlbTÝÝ lsW MGB½ lXNSúT mñ wYM lÍB¶µ _Ê :”nT y¸Wl# LW_ HÃêN t-!nW

Ylqq$b¬L y¸ÆlW ï¬ y¸ÙÙz#bT mNgDN½ y¸¹-#bT ygbà ï¬N½ tÍss#N ktÍss#

b¬C ÃlWN ï¬ h#l# Ã-”l§LÝÝ

a) Description of the proposed deliberate release, including the purpose and foreseen

outcome.

b) Planned dates and durations of the release.

c) Size of the site.

d) Method to be used for the release.

e) Quantity of modified organism to be released.

f) Site preparation prior to release (type and method of cultivation, mining, irrigation,

or other activities).

g) Worker protection measures to be taken during the release.

h) Post-release treatment of the site.

i) Techniques foreseen for elimination or inactivation of the modified organism at

the end of the experiment or use.

j) Information on, and results of, previous releases of the modified organism

especially at different scales and in different ecosystems.

21
6.2 Information on the environment

Complete information should be given both on the site and on the wider environment of

the intended release. Note that in the case of modified organisms destined to be used as

food or feed or for processing, the environment of deliberate release includes the

transportation routes and the market places as well as all the catchments and downstream

areas.

h. t-!ñ የሚደረገው LqT y¸fiMbT ï¬ mLK› MD‰êE xq¥m_ wd s»N wd M|

‰Q bSNT Ä!G¶ XNd¸g"½

l. lsW ll@lÖC yBZ/ ?YwT KMCT ï¬ãC½ _BQ xµÆb!ãCN =Mé½ ÃlW

mLK› MD‰êE Sn?Yw¬êE QRbT½

/. የአካባቢው y?ZB B²T½

m. bxµÆb!W ytf_é hBèC §Y ytm\rtW yxµÆb!W ¥~brsïC x!÷ñ¸ÃêE

XNQS”s@½

\. bQRbt$ µl# l¸-È Ni#H W¦ wYM lxµÆb!ÃêE MKNÃT ktkll# ï¬ãC ÃlW

RqT½

r. yï¬W yxyR NBrT½

s. yï¬W yz#RÃW mLK› MD‰êE½ Sn MD‰êE yxfR ÆHRÃT½

¹. bxµÆb!W y¸gß# :ፀ êT XNSúT½ ysBL xZR:TN½ yb@T XNSúTNÂ

DNbR zlL tNqú”> ZRÃãCN =Mé½

q. bq_¬ y¸nk# btzêê¶ l!nk# y¸Cl# |R›t m?DéC½

b. yLW-#Â ÃLtlw-W xÒW ?Ãên# ytf_é SF‰ LqT k¸fiMbT SF‰ U‰ ÃlW

N}}R½

22
 t. Lqt$ l!ÃmÈW y¸ClWN t{:ñ l!lW-# y¸Cl# b:QD ytÃz# yï¬W L¥èC wYM

yx-”qM lWõC½

7. በ LW_ ሕያዉ X bxµÆb!W mµkL l!ñR y¸CL GNß#nTN y¸mlkt$

mr©ãC½

7.1 bHYwT möyT½ m‰ÆT½ m²mT yÆHRY KStT¿

h. የ LW_ ሕያዉ möyT ን ½ m‰ÆTN ና m²mT ን y¸wSn# Sn ?Yw¬êE

h#n@¬ãC½

a) Geographical location and grid reference of the site of release.

b) Physical and biological proximity to humans and other significant biota, including

protected areas.

c) Size of local population.

d) Economic activities of local populations which are based on the natural resources

of the area.

e) Distance to closest areas protected for drinking water or environmental purpose

f) Climatic characteristics of the area.

g) Geographical, geological and pedological characteristics of the site and of its

surroundings.

h) Flora and fauna, including crops, livestock and migratory species of the area.

i) Description of target and non-target ecosystems likely to be affected.

j) A comparison of the natural habitat of the recipient and modified organism with

the proposed site of release.

23
 k) Planned developments or changes in land use in the area which could influence

the environmental impact of the release.

7. Information relating to the interactions between the modified organism

and the environment

7.1 Survival, multiplication, dispersal and trait expression

a) Biological features which affect the survival, multiplication and dispersal of the

modified organism.

l. የ LW_ ሕያዉ ወይም የዘ r መሉ ወይም የሌሎች yÆ?RY KStT nK N_r ngéc$

y¸¬wq$ wYM y¸-bq$ b?YwT möyTN½ m‰ÆTN m²mTN y¸wSn#

xµÆb!ÃêE h#n@¬ãC (nÍS½ W¦½ xfR½ xs!Ä¥nT½ XN ደ ir tÆY à ሉ

bµ×C½ kÆD BrT msL ¥:DÂT½ yzrmL bdqEQ xµ§T bk#L mt§lF XÂ

l@lÖC)ÝÝ

7.2 kxµÆb! UR y¸ñR Gn#"nT

h lLW_ ሕያዉ tS¥¸ YçÂl# tBlW y¸gmt$T yï¬ ›YnèC½

l. XNd ¥údg!à KFlÖC ymStêT b@èC Æl# XNd tf_éxêE ï¬W bçn# sW s

‰> ï¬ãC bLW_ ?Ãý Æ?RÃT §Y ytdrg# MRMéC LW_ ?Ãý y¸ÃúDrW

Snm?D‰êE t}:ñ GMg¥½

/. yÆ?RY ¥UÆT ClÖ¬W½

1. kt-@nW LqT b“§ kLW_ ሕያዉ btlqqbT tÍsS kRs# wd¬C Æl#T SR›t m?

DéC wd¸ñ„ l@lÖC ?ÃêN yzrmlÖC wYM yl@lÖC yÆ?RY KStT nK N_r

ngéC ymUÆT :DL½

24
 2. kLqT b“§ b|R›t m?Déc$ k¸gß#T ?ÃêN wd LW_  ሕያዉ yzrmlÖC wYM

yl@lÖC yÆ?RY KStT nK N_r ngéC mUÆT :DL½

m. kt-@nW LqT b“§ l!ñR b¸ClW GNß#T MKNÃT bLW ጥ ሕያዉ l!ÃU_M

y¸CL ÃLt-bq wYM y¥YflG yÆHRY lW_½

b) Known or predicted environmental conditions which may affect survival,

multiplication and dispersal (wind, water, soil, temperature, pH, pollutants such as

pesticides, heavy metals, horizontal gene transfer and others) of the modified

organism or of its genes or other biochemicals that affect trait expression.

7.2 Interactions with the environment

a) Habitat types expected to be suitable for the modified organism.

b) Experiments carried out on the behaviour of the modified organism and an assessment

of its ecological impact carried out in simulated natural environments, such as growth

rooms and greenhouses.

c) Trait transfer capability.

1) Possibility for post-release transfer of genetic materials or other chemicals

that affect trait expression from the modified organism into organisms in

ecosystems of the release site and its catchment and downstream area.

2) Possibility for post-release transfer of genetic material or other trait

affecting chemical from organisms in the ecosystems to the modified organism.

d) Likelihood of post-release interaction leading to the expression of unexpected or

undesirable traits in the modified organism.

25
 \. yLW_ ሕ à ዉ zrm§êE mrUUTN l¥rUg_ h#n@¬WN l¥wQ y¸wsÇ

XRM©ãC¿ zrmlÖC wYM l@lÖC yÆ?RY KStT nK N_r ngéC wd l@lÖC ?

ÃêN XNÄYt§lû l¥DrG y¸ÃSCl# ÆHRÃT¿ ymrUUt$ XWNnT

y¸rUg_ÆcW zÁãC½

r. yLW_ ሕያ ý ym²mÒ mNgìC½ y¸¬wq$ wYM y¸gmt$ kx²¥C ?ÃêN UR

y¸ñ„ Gn#"nèC½ ከ nÍS½ ከ W`½ kTNÍ> UR mGÆT ን ½ kMGB UR

mGÆT ን ½ xµ§êE NKk!T wd XNSúT xµ§T sRSé mGÆT ን  l@lÖC ን

ጨምሮ ½

s. LW_ ሕያዉ l!dRSÆcW YCl# YçÂL tBlW y¸gmt$T SR›t m?DéC glÚ½

7.3 l!dRs# y¸Cl# yxµÆb! t}:ñãC

h. yLW_ ሕያ ý bxµÆb!W WS_ XJG bÈM ymƲT xQM½

l. LW_ ሕያ ý LW_ µLçn#T wYM w§J ZRÃãC U‰ ÃlW ytwÄĶnT BLŽ

/. kLW_ ሕያ ý t{:ñ XNÄ!dRSÆcW ›!§¥ yçn#T ZRÃãC ZRZR mGlŽ

m. btlqqW LW_ ሕያ W X ለ›!§¥nT b¬sb#T ZRÃãC mµkL y¸ñrW Gn#"nTÂ

y¸-bqW W-@T፣

\. t}:ñ l!dRSÆcW y¸Cl# bx!§¥nT ÃL¬qÇ ZRÃãC ¥NnT ZRZR½

r. kLqT b“§ l!m-# y¸Cl# Sn ?Yw¬êE lWõC wYM yLW_ ?à ዉ ›!§¥ x¥‰ôC½

e) Measures to be employed to ensure and to verify genetic stability. Description of

traits which may prevent the transfer of genetic materials or other trait affecting

chemicals. Methods to verify stability.

26
 f) Routes of biological dispersal of the modified organism, known or potential

modes of interaction with disseminating agents, including dispersal by wind,

water, inhalation, ingestion, surface contact with or burrowing into animals, and

others.

g) Description of ecosystems to which the modified organism could be disseminated.

7.3 Potential environmental impacts

a) Potential for excessive population increase of the modified organism in the

environment.

b) Competitive advantage of the modified organism in relation to the unmodified or

parental species.

c) Identification and description of the target species that are intended to be affected

by the modified organism.

d) Anticipated mechanism and result of interaction between the released modified

organism and the target species.

e) Identification and description of non-target species which may be affected.

f) Likelihood of post-release shifts in biological or in target range.

s. y¬w ቁ wYM y¸gmt$ btwÄĶãC½ btb‘ãC½ b›!§¥ãC½ btdUUðãC½ bb‘ãC½

b_g®C XÂ bb>¬ xMÀãC §Y l!dRs# y¸Cl# t}:ñãC½

¹. y¸¬wQ wYM y¸gmT LW_ ሕያ ý bSnm?D‰êE ?YwT nK yN_r ngéC ;#dT

§Y y¸ñrW ¸Â½

q. l@lÖC wú" y¸Æl# kxµÆb! UR y¸ñ„ Gn#"nèC½

27
8. yKTTL½ yq$__R½ öšš y¥MkNÂ yxdU mk§kL :QìC mr©ãC
8.1 yKTTL mNgìC

h. LW_ ሕያ ýN የ mlày¸ÃSkTlWN t}:ñ የ mk¬tà zÁãC½

l. የክትትል ዘዴ ã ቹ LW-#N ሕያ W ksÀ½ ktqÆY QRbT µ§cW l@lÖC ?ÃêN

l‘nT½ lk!nTÂ xSt¥¥"nT½

/. wd LW_ ሕ à ዉ WS_ ygÆWN ÆYtêR zrmL wYM N_r ng‰êE Yzt$ ytlw-

bT zrmL wYM ßétEN wYM l@§ yÆ?RY KStT nK N_r ngR wd l@lÖC ?

ÃêN mt§lFN y¥wQÃ zÁãC½

m. tgb! ÃLçn# yÆ?RY KStèCNÂ mNSx@ãÒcWN ¥wQÃ mNgìC½

8.2 Lqt$N SlmöÈ-R

h. ytlqqW LW_ ሕያ W ktlqqbT wYM b_QM §Y XNÄ!WL ktwsnlT ï¬ WÀ

XNÄY²mT ¥g© zÁãCÂ xtgÆb‰cW½

g) Known or predicted effects on population levels of competitors, preys, hosts,

symbionts, predators, parasites and pathogens.

h) Known or predicted involvement of the modified organism in biogeochemical

processes.

i) Other potentially significant interactions with the environment.

8. Information on monitoring, control, waste treatment and emergency response

plans

28
 8.1 Monitoring techniques

a) Methods for tracing the modified organism and for monitoring its effects.

b) Specificity (to identify the modified organism and to distinguish it from the

donor, recipient or the related organisms), sensitivity and reliability of the

monitoring techniques.

c) Techniques for detecting the transfer of the introduced transgene or chemically

changed gene or protien or other trait affecting chemical to other organisms.

d) Methods for detecting aberrant expression of traits and their causes.

8.2 Control of the release

a) Methods and procedures to avoid the spread of the modified organism beyond the

site of release or the designated area of use

l. ÃLtfqd§cW sãC wd ï¬W XNÄYgb# y¸klkl#ÆcW zÁãC xtgÆb‰cW½

/. l@lÖC ?ÃêN wd ï¬W XNÄYdRs# mk§kà zÁãC xtgÆb‰cW½

8.3 yöšš xwUgD

h. y¸wÈW yöšš ›YnT½

l. y¸-bqW yöšš m-N½

/. l!dRs# y¸Cl# -NöC½

m. y¬q ዱ öšš y¥Mk¾ mNgìC ZRZR½

8.4 yxdU mÌÌM :QD

29
 h. የ LW_ ሕያ ý ÃL¬sb m²mT b!ÃU_M y¸wsÇ ymöÈ-¶Ã zÁãCÂ

xtgÆbéÒcW½

l. ÆL¬sbW m²mT ytbklWN xµÆb! y¥}© wYM LW_  ሕያ ýN y¥Mk¾

zÁãC½

/. ÃLt-bq m²mT s!ÃU_M ytUl-# XiêTN½ XNSúTN XÂ xfRN y¥}© wYM

y¥Swg© zÁãC½

m. ÆLt-bqW m²mT yt-”WN ï¬ zGè kxµÆb!W mn-à zÁãC½

\. y¥YflG h#n@¬ b!ÃU_M ysWN yxµÆb!N dHNnT lm-bQ y¸ÃSCL :QD½

9. LW_  ሕያ WN lgbà l¥QrB mzRzR ÃlÆcW t=¥¶ mr©ãC xmLµc$

y¸qblW GÁ¬

b) Methods and procedures to protect the site from intrusion by unauthorized

individuals.

c) Methods and procedures to prevent other organisms from entering the site.

8.3 Waste treatment

a) Type of waste that will be generated.

b) Expected amount of waste.
c) Possible risks.
d) Description of methods of treatment planned.

8.4 Emergency response plan

a) Methods and procedures for controlling the modified organism in case of

unexpected spread.

30
 b) Methods for the decontamination of, or for the eradication of the modified

organism from the area.

c) Methods for disposal or sanitation of plants, animals and soils that were exposed

during the unexpected spread.

d) Methods for the isolation of the area affected by the unexpected spread.

e) Plans for protecting human health and the environment in case of the occurrence

of an undesirable effect.

9. Additional information required in the case of notification for placing a

commodity consisting of a modified organism on the market and the obligation
that the applicant shall accept.

9.1 LW_ ሕያ W ወይም ከልውጥ ሕያው የተሰራ ነገር ÃlbTN ¹q_ wd gbà l¥QrB b¸qRB

¥mLkÒ y¸ktl#TN t=¥¶ mr©ãC ¥QrB ÃSfLULÝÝ

h. y¹q-# SMÂ bWS-# yÃzW LW_ HÃW úYNúêE SM½ ytlMì SMÂ ytlw-bT

KNên@½

l. yLW_ HÃý \¶Â xkÍÍY SäC xD‰šãC½ ySLK q$_éCN x!-»YlÖCN

=Mé½

/. bPéè÷l# ymr© SR›T WS_ Sl LW_ ?Ãý mr© ¥GßT y¸ÒLbT mNgD mGlŽ

m. lMN _QM XNd¸WL ¥úwQ½ lsW MGB½ lXNSúT mñ½ wYM lÍB¶µ

_Ê :”nT½

\. lxkmÒct$ l¬qdlT _QM l¥êl# y¸ÃSfLg# mm¶ÃãC½

31
 9.2 y¸ktl#T mr©ãC በአማርኛና በእንግሊዝኛ ቋንቋዎች ተፅፈው ¹q-#N bÃz#T _QlÖC

§Y bGL} m¬yT xlÆcW¿ YH h#l# g!z@ XNd¸drGM xmLµc$ b¥mLkÒW

GÁ¬ mqbL xlbT

h. SäC xD‰šãC½

1. ySLK q$_RN x!»YLN =Mé y¹q-# §k! SM xD‰š½

2. ySLK q$_RN x!»YLN =Mé y¹q-# tqÆY SM xD‰š½

l. b¹q-# WS_ yLW_ HÃêN zR µl «LW_ HÃêNN Y²*L´ y¸l# ”§T t{fW ml-F

xlÆcW½

/. b¹q-# WS_ kLW_ ?ÃW yt ሠራ ምግብ ወይም ሌላ የፍጆታ ዕቃ s!g"½ «kLW_ ?

ÃêN yt\‰´ y¸l# ”§T t{fW ml-F xlÆcW½

9.1 The following additional information shall be provided in the application for

placing a commodity that is made of a modified organism or that has any part

taken from a modified organism on the market:

a) Name of the commodity, the scientific and common names and the

transformation event of the modified organism.

b) Names and addresses, including telephone numbers and e-mails, of the maker and

the distributor of the modified organism.

c) Specification for accessing information on the modified organism in the Biosafety

Clearing House of the Protocol.

d) Type of expected use: food, feed or processing

e) Specific instructions for storage and handling

32
9.2 The following information shall be shown clearly in both Amharic and English
on each package containing the commodity, and the applicant shall undertake in
his application that this shall always be done
a) Names and Addresses

1. Name and address, including telephone number and e-mail, of sender of the
commodity.

2. Name and addresses, including telephone number and e-mail, of receiver of

the commodity.

b) The words "Contains modified organisms” shall be written on the label

whenever it is known that there are modified organisms in the commodity.
c) When the commodity is a food item or any other consumer prooduct, the words

“Processed from modified organisms” shall be written on the label.

m. kz!H b¬C yt-qs#T yLW_ ?Ãên# mGlÅãC bx¥R¾Â b እንግሊዝኛ t{fW Yl-

ûb¬L½

1. úYNúêE SM½

2. ytlm ዶ SM½

3. ytlw-bT KNên@½

4. yGL mlÃW½ µlW½

5. ytkstW xÄ!S ÆHRY½

6. kxÄ!s# wYM ktÃÃz# l@lÖC lWõC ym-# L† ÆHRÃT½

\. ¹q-# LW_ ?ÃW y¥Yg"bT ወይም ከልውጥ ሕያው ያልተሠራ mçn# XRG-¾ s!÷N

"LW_ ?ÃW ylbTM"½ y¸L በአማርኛና በእንግሊዝኛ የተፃፈ ጽሑፍ l!l-FbT

YC§LÝÝ

33
10. መመሪያ W የሚፀናበት ጊዜ

ይህ መመሪያ ከ.............ቀን..............ዓ.ም ጀምሮ የፀና ይሆናል፡፡

አዲስ አበባ ................ቀን ..........ዓ.ም

የአካባቢ MKR b@T sBúb!

d) A specification of the modified organisms shall also be written both in Amharic and

in English on the label.

1. The scientific name.

2. The common name.

3. The transformation event.

4. The unique identifier, where available.

5. The expressed new trait.

6. Properties that arise from the new trait or from other related changes.

e) The words “Contains no modified organisms” may be written on the label in both

Amharic and English when the product is known to have been processed from

products that do not contain any modified organisms.

10. Effective Date

34
This directive shall enter into force as of the---- day of 200….

Done at Addis Ababa, this ---- day of ------- 200….

Chairperson of the Environmental Council

35